Connect with us

Business

Super Micro CEO Charles Liang said he teamed up with Elon Musk’s xAI to build the Colossus data center in just 122 days

Published

on



  • Super Micro Computer, a Fortune 500 Silicon Valley tech giant that manufactures high-efficiency servers and data centers, is setting its sights on expanding in the Midwest and East coast regions and hopes to stave off the hit from higher prices due to President Trump’s tariffs, said CEO Charles Liang on Thursday. The company recently partnered with xAI and its Grok team to build a data center in Tennessee. 

Super Micro Computer is looking to turn the page after an arduous slog through a host of accounting and finance issues. The data center manufacturer is working toward a $40 billion revenue target and CEO Charles Liang announced plans to expand from its San Jose campus to new locations in the Midwest and East Coast. Super Micro is in talks with potential partners in the Middle East, he added. Liang spoke at the HumanX AI conference in Las Vegas this week.

He touted the Memphis data center, and said the company assembles its racks in San Jose before it ships components out to customers who can then “plug and play.” The company is a key piece of the AI ecosystem, and its fortunes have risen along with those of Nvidia, OpenAI, Anthropic and others as demand for data center servers needed for operating and training AI models has soared. Liang, who founded the company in 1993 with five people before it grew into a $23 billion Fortune 500 player, counts Nvidia CEO Jensen Huang as a friend, and Super Micro’s servers are packed with Nvidia’s highly coveted GPUs. 

In fact, the new 750,000 square foot xAI Colossus cluster Super Micro built for Elon Musk’s xAI Grok team counts 100,000 Nvidia H100 GPUs, the company said in a recent case study

“It took Elon and Super Micro only 122 days to finish,” said Liang, adding that it would usually take a year or longer to build such a data center. “He pushed me a lot, and he has high standards.”

And despite the aftermath of DeepSeek and China’s Manus AI, comingled with talk that companies will scale back on spending, Liang said what’s happening now is that the dynamic environment in tech is being brought back into “balance.”

Ultimately, however, he predicted demand will continue to surge over the next five to 10 years as companies seek the best, most efficient products. 

“This AI boom has been very big and AI now is so powerful,” said Liang. “But AI can be much more powerful, much faster, smarter, and more user-friendly…. There’s more room for AI to grow.”

He also noted that President Trump’s 25% tariffs on steel and aluminum imports aren’t likely to be as meaningful a hit to the company because it has kept its operations U.S.-based. Liang said the company also plans to leverage its footprint in Taiwan. One of its major contract manufacturers, Ablecom, is based in Taiwan along with its distributor, Compuware. The two companies’ CEOs, Steve Liang and Bill Liang, respectively, are Charle’s Liang’s brothers. 

Those and other related-party transactions led to a short seller report last year amid other accounting red flags that catapulted Super Micro into a financial-reporting gridlock in which it delayed its annual 10-K and quarterly financial filings. Its auditor EY quit in the middle of an engagement and Super Micro was in danger of being delisted from Nasdaq, which would have been the second time such a thing occurred. 

Last month, Super Micro issued belated annual financial reports and said its former accounting firm was to blame for the delay. The company has since been hit with at least five lawsuits and faces a probe from the Department of Justice and the Securities and Exchange Commission. Super Micro is cooperating with regulators. 

This story was originally featured on Fortune.com



Source link

Continue Reading

Business

Dr. Oz says probiotic supplements have wide-ranging health benefits. Here’s what science says

Published

on



Our bodies—and guts, specifically—depend on a balance of bacteria to “maintain healthy blood sugar and cholesterol levels,” but “you gotta feed the bacteria.” So said Dr. Mehmet Oz—heart surgeon turned daytime TV host, ardent RFK Jr. supporter, believer in disproven COVID treatment hydroxychloroquine, and now possible head of Medicaid and Medicare for the Trump administration—who began his Senate confirmation process on Friday

To aid in that gut-balancing process, Oz has pushed the benefits of both prebiotics and probiotics, including in his role as global advisor for the iHerb brand of supplements. 

Both have come under scrutiny recently, including through this week’s Washington Post opinion piece by Harvard medical school instructor and physician Trisha Pasricha, who called probiotics “a waste of money,” instead recommending a high-fiber diet

So which doctor is right? Here’s what science tells us. 

What are probiotics?

The human gastrointestinal tract is colonized by a range of microorganisms, including bacteria, archaea, viruses, fungi, and protozoa, explains the National Institutes of Health (NIH) Office of Dietary Supplements. And the activity and composition of those microorganisms (often known as the gut microbiome) can affect human health and disease.

Probiotics, according to the International Scientific Association for Probiotics and Prebiotics, are “live microorganisms that, when administered in adequate amounts,” may benefit that gut microbiome composition. 

While they are naturally present in fermented foods—including the homemade turmeric sauerkraut Dr. Oz mentions in his Instagram post (above) about probiotics—they can also be added to food products, and are available as dietary supplements. 

“However,” notes the NIH, “not all foods and dietary supplements labeled as probiotics on the market have proven health benefits.”

That’s where a range of varied opinions come into play.

Who says what about probiotic supplements?

As Pasricha points out, of the over 1,000 clinical trials of probiotic supplements, there have been too many different strains tested and results found to reliably say they can be universally helpful. 

A 2024 review of existing evidence, published in the Advances in Nutrition journal, concluded that, on one hand, “there is sufficient evidence of efficacy and safety for clinicians and consumers to consider using specific probiotics for some indications—such as the use of probiotics to support gut function during antibiotic use or to reduce the risk of respiratory tract infections—for certain people.”

However, those researchers concluded, “we did not find a sufficiently high level of evidence to support unconditional, population-wide recommendations for other preventive endpoints we reviewed for healthy people. Although evidence for some indications is suggestive of the preventive benefits of probiotics, additional research is needed.”

When looking at the body of scientific evidence regarding effect of probiotics on seven different health issues, the NIH reports the following:

Atopic dermatitis

Numerous studies have looked at the effect of probiotics on this most common form of eczema. Overall, the evidence suggests that the use of probiotics might reduce the risk of developing atopic dermatitis, but also might provide only limited relief. The effects also depend on the strain used, the timing of administration, and the patient’s age.

Pediatric acute diarrhea

While one large review found that single- and multi-strain probiotics significantly shortened the duration of symptoms, another found it was no better than a placebo. 

Antibiotic-associated diarrhea

Overall, the available evidence suggests that starting probiotic treatment with strains LGG (Lactobacillus) or Saccharomyces boulardii within 2 days of the first antibiotic dose helps reduce the risk of diarrhea in patients between 18 and 64, but not in elderly adults.

Inflammatory bowel disease

IBD is a chronic inflammatory disease that includes ulcerative colitis and Crohn’s disease, for which no cure exists. In the many reviews that have looked at the effects of probiotics, researchers reached similar conclusions—that certain probiotics might have modestly beneficial effects on ulcerative colitis but not on Crohn’s disease.

Irritable bowel syndrome

IBS is a common functional disorder of the gastrointestinal tract that’s been linked to both stress and gut microbiomes. Overall, the available evidence shows that probiotics might reduce some symptoms, but stresses that additional clinical trials are needed to confirm the specifics of strain, dose, and duration of treatment.

High cholesterol

Researchers have studied the use of probiotics to improve lipid profiles. And while, overall, research suggests that using multiple probiotic strains might reduce total and LDL (bad) cholesterol levels, more research is needed.

Obesity

Again: More research is needed. The results, the NIH concludes, “indicate that the effects of probiotics on body weight and obesity might depend on several factors, including the probiotic strain, dose, and duration as well as certain characteristics of the user, including age, sex, and baseline body weight.” 

Bottom line: The jury is still out. Whether you opt to try the supplements or not (as they are generally believed to be harmless, though long-term safety studies are still needed), make sure to eat plenty of fiber as well as fermented foods. That includes yogurt, kefir, fermented cottage cheese, kimchi and other fermented vegetables (as endorsed by Oz), and kombucha tea, which were shown by Stanford University researchers to increase microbial diversity and lower inflammation.

More on supplements:

This story was originally featured on Fortune.com



Source link

Continue Reading

Business

Here’s when AI will launch a decade-long cycle of economic growth and productivity gains

Published

on

© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.



Source link

Continue Reading

Business

Gen Z Americans don’t have enough saved to cover a single month of spending

Published

on

© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.



Source link

Continue Reading

Trending

Copyright © Miami Select.